PL EN


Preferences help
enabled [disable] Abstract
Number of results
2018 | 73 | 1 |
Article title

Strategies in poorly soluble drug delivery systems

Content
Title variants
Languages of publication
EN
Abstracts
EN
The form of the active drug administered to patients is important as far as effectiveness of the disease therapy is concerned. From this point of view modifications of medicinal substances are searched for that the obtained compounds have the best physicochemical and pharmacodynamic properties. Pharmaceutical companies allocate significant funds for this type of research. The key property that needs to be improved is the solubility of biologically active substances. This is related to the fact that over 40% of drugs available on the pharmaceutical market are characterized by low solubility in water.Thus, the paper describes the most important strategies used in the poorly soluble drug delivery systems, e.g. physical and chemical modifications, formulation based, modification of partition coefficient and lipid systems. The authors discussed various techniques used to enhance solubility of poorly water soluble drugs with their advantages and limitations.
Year
Volume
73
Issue
1
Physical description
Dates
published
2018
online
2019-11-06
Contributors
References
  • [1] H. Lennernäs, B. Abrahamsson, Journal of Pharmacy and Pharmacology, 57, 273-285, (2015).
  • [2] K.T. Savjani, A.K. Gajjar, J.K.Savjani, International Scholarly Research Network, 195727, (2012).
  • [3] S.R.K. Yellela, Journal of Bioequivalence&Bioavailability, 2, 28-36, 2010.
  • [4] K.H. Edward, D. Li, in: Drug Like Properties: Concept, Structure, Design and Methods, from ADME to Toxicity Optimization, Elsevier, p. 56., 2008.
  • [5] V.R. Vemula, V. Lagishetty, S. Lingala, International Journal of Pharmaceutical Sciences Review and Research, 5, 41-51, (2010).
  • [6] D. Sharma, M. Soni, S. Kumar, G.D. Cupta, Research Journal of Pharmacy and Technology, 2, 220-224, (2009).
  • [7] M.R. Baig, A. Shahiwala, S.A. Khan, Advancements in Bioequivalence&Bioavailability, 1, 1-4, (2018).
  • [8] D. Brahmankar, S.B. Jaiswal, in: Biopharmaceutics and
  • Pharmacokinetics – A treaties, New Delhi, Vallabh Prakashan, 1995.
  • [9] A.P. Gowardhane, N.V.Kadam, S. Dutta, American Journal of Drug Discovery and Development, 4, 134-152, (2014).
  • [10] G. Nykamp, U. Carstensen, B.W. Muller, International Journal of Pharmaceutics, 242, 79-86, (2002).
  • [11] N. Bladgen, M. de Matas, P.T. Gavan, P. York, Advanced Drug Delivery Reviews, 59, 617-630, (2007).
  • [12] V.R. Patel, Y.K. Agrawal, Journal of Advanced Pharmaceutical Technology&Research, 2, 81-87, 2011.
  • [13] T. Patole, A. Deshpande, International Journal of Pharmaceutical Sciences and Research, 5, 3566-3576, (2014).
  • [14] R. Thakuria, A. Delori, W. Jones M.P. Lipert, L. Roy, N. Rodriguez-Hornedo, International Journal of Pharmaceutics, 435, 101-125, (2013).
  • [15] A.T. Serajuddin, Advanced Drug Delivery Reviews, 59, 603-616, (2007).
  • [16] L. Shargil, Yu, in: Applied biopharmaceutics and pharmacokinetics, Appleton-century crofts, 193-203, 1985.
  • [17] E. Nelson, Journal of American Pharmaceutical Association (Scientific Edition), 47, 297-299, (1958).
  • [18] S.M. Berge, L.D. Bighley, D.C. Monkhouse, Journal of Pharmaceutical Sciences, 66, 1-19, (1977).
  • [19] B.D. Anderson, R.A. Conradi, Journal of Pharmaceutical Sciences, 74, 815-820, (1985).
  • [20] P. Makary, Pharmaceutical and Biosciences Journal, 2, 1-4, (2014).
  • [21]
  • [22] R.K. Parikh, NS. Mansuri, M.C. Gohel, M.M. Soniwala, Indian Drugs, 42, 149-154, (2005).
  • [23] S. Göktürk, E. Çalışkan, R. Yeşim Talman, U. Var, The Scientific World Journal, 718791, (2012).
  • [24] T. Loftsson, M.E. Brewster, Journal of Pharmaceutical Sciences, 85, 1017-1025, (1996).
  • [25] K. Uekama, F. Hirayama, T. Irie, Chemical Reviews, 98, 2045-2076, (1998).
  • [26] D.O. Thompson, Critical Reviews in Therapeutical Drug Carrier System, 14, 1-104, (1997).
  • [27] C. Neuberg, Biochemistry, 76, 107-109, (1916).
  • [28] A.M. Saleh, N.A. Daabis, Pharmazie, 29, 525-527, (1974).
  • [29] A.A. Badwana, L.K. Khordaguib, A.M. Saleh, S.A. Khalil, International Journal of Pharmaceutics, 19, 67-74, (1982).
  • [30] D. Balasubramanian, S.E. Friberg, in: Surface and Colloid Science, Plenum Press, New York, 15, 197-220, 1993.
  • [31] K. Nidhi, S. Indrajeet, M. Khushboo, K. Gauri, D.J. Sen, International Journal od Drug Development and Research, 3, 26-33, (2011).
  • [32]S.H. Yalkowsky, J.T. Rubino, Journal of Pharmaceutical Sciences, 90, 416-421, (1985).
  • [33] J.,T. Rubino, S.H. Yalkowsky, Pharmaceutical Research, 4, 231-236, (1987).
  • [34] K. Sekiguchi, N. Obi, Chemical and Pharmaceutical Bulletin, 9, 866-872, (1961).
  • [35] I. Durate, M. Temtem, M. Gil, F. Gaspar, India Pharmacy, 30, 4-6, (2011).
  • [36] S. Sinka, M. Ali, S. Baboota, A. Ahuja, A. Kumar, J. Ali, American Association of Pharmaceutical Scientist, 11, 518-527, (2010).
  • [37] I. Sridhar, A. Doshi, B. Joshi, V. Wankhede, J. Doshi, Journal of Scientific and Innovative Research, 2, 685-694, (2013).
  • [38] S.A.A. Talegonkar, F.J. Ahmad, R.K. Khar, S.A. Pathan, Z.I. Khan, Recent Patents on Drug Delivery&Formulation, 2, 238-257, (2008).
  • [39] S. Heschkel, A. Goebel, R.H.H. Neubert, Journal of Pharmaceutical Sciences, 97, 603-631, (2008).
  • [40] A. Spernath, A. Aserin, Advanced in Colloid and Interface Science, 128-130, 47-64, (2006).
  • [41] L.B. Lopes, Pharmaceutics, 6, 52-77, (2014).
  • [42] K. Ogino, M. Abe, in: Surface and Colloid Science, Plenum Press, New York, 85-95, 1993.
  • [43] B.K. Paul, S.P. Moulik, Journal of Dispersion Science and Technology, 18, 301-304, (1997).
  • [44] S.N. Tenjarla, Therapeutic Drug Carrier Systems, 16, 461-521, (1999).
  • [45] E.A. Mahmoud, E.R. Bendas, M.I. Mohamed, AAPS PharmSciTech, 10, 183-192, (2009).
  • [46] S. Nazzal, M.A. Khan, International Journal of Pharmaceutics, 315, 110-121, (2006).
  • [47] C. Sander, P. Holm, AAPS PharmSciTech, 10, 1388-1395, (2009).
  • [48] M.J. Rosen, in: Surfactants and interfacial phenomena, John Wiley&Sons, New York, 1989.
  • [49] A.T. Florence, D. Attwood, in: Physicochemical Principles of Pharmcacy, The McMillan Press, London, 2003.
  • [50] C.O. Rangel-Yagui, A. Pessoa, L.C. Tavares, Journal od Pharmacy and Pharmaceutical Sciences, 8, 147-163, (2005).
  • [51] Y.E. Alaoui, R. Sefrioui, Y. Bensouda, Y. Rahali, Journal of Chemical and Pharmaceutical Research, 7, 39-46, (2014).
  • [52] W. Xu, P. Ling, T. Zhang, Journal of Drug Delivery, 340315, (2013).
  • [53] J.S. Dua, A.C. Rana, A.K. Bhandari, International Journal of Pharmaceutical Studies and Research, 3, 14-20, (2012).
  • [54] S. Kalepu, S. Kumar, S. Bertha, M. Varma, International Journal of Drug Development&Research, 4, 62-75, (2013).
  • [55] D. Yadav, K. Sandeep, D. Pandey, R.K. Dutta, Journal of Biotechnology and Biomaterials, 7, 276, (2017).
  • [56] G. Bozzuto, A. Molinari, International Journal of Nanomedicine, 10, 975-999, (2015).
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.ojs-doi-10_17951_aa_2018_73_1_81-98
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.